BioCentury
ARTICLE | Financial News

Aclaris prices $75M follow-on

August 18, 2017 4:30 PM UTC

On Aug. 10, Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $75 million through the sale of 3.3 million shares in a follow-on underwritten by Jefferies, Leerink, William Blair, Guggenheim and JMP Securities...

BCIQ Company Profiles

Aclaris Therapeutics Inc.